Lara Mott

Lara Mott has a diverse work experience in various roles within the healthcare and investment sectors. Lara co-founded ImproveWell LTD in 2016 and served as the CEO, focusing on digital staff engagement solutions for healthcare improvement. Lara was also an Entrepreneur in Residence at BMJ from 2019 to 2021. Prior to that, they held roles such as Deputy Chair of the Communications Advisory Committee at the BioIndustry Association and Director of Investor Relations at GHO Capital Partners LLP. Lara's experience also includes serving as a board member at Selfless, Vice President of Corporate Affairs at Circassia, and Head of Investor Relations and Corporate Communications at Oxford BioMedica. Lara started their career as a Research Analyst at Höegh Capital Partners Advisors Ltd. Overall, Lara has a strong background in communications, investor relations, and healthcare innovation.

Lara Mott holds a first-class BSc Hons degree in Pharmacology from the University of Bristol. Prior to their university education, they attended Kingston Grammar School, where they served as the Vice-Captain. The specific start and end years for both their university and high school education are not provided.